-Hindustan Times School textbooks in recent decades have frequently become battlegrounds for ideological contestation in India. Most textbook wars are to advance majoritarian perspectives on history and culture. However, a recent very different textbook skirmish broke out about the public and private sectors in healthcare. The story of this ideological clash is bemusing and instructive, illuminating competing perspectives on the nature of education, healthcare and markets in new India. This clash surfaced...

-The Times of India NEW DELHI: Over 200 cancer drugs, 186 medicines to treat cardiovascular diseases and 148 stents and cardiac implants will now be available at central government hospitals at prices 50-60% lower than the open market. The health ministry has launched a programme called AMRIT (Affordable medicines and Reliable Implants for Treatment), under which the government will run pharmacy retail stores to sell medicines in hospitals like All India Institute...

-The Times of India NEW DELHI: In an attempt to ease norms for testing and introduction of new medicines in the country, the government has taken steps to fast-track approvals for clinical trials as well as launch of drugs already approved in other countries. Pharmaceutical companies planning to launch new drugs already approved outside India after conducting pre-clinical or toxicological studies on animals will not be required to repeat such studies in...

-The Hindu We need to take AIDS out of isolation and look at it in a broader framework, with links to maternal and child health, says Michel Sidibe, Executive Director of UNAIDS. Speaking on the sidelines of the India Africa Forum Summit, Michel Sidibe, Executive Director, UNAIDS, admitted to being ‘scared’ as pressure mounts on India to relax norms, allowing patent protection. In a conversation with Vidya Krishnan, Mr. Sidibe also spoke...

-The Times of India NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight. The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs...